Hospitals throughout India have started using humanoid robots to assist with the treatment of COVID-19 patients—and it’s making a big impact.  

AI-powered chatbots aren’t human. However, in a way, they’re still persons. One that would like to be your always-available talk therapist says so.

As researchers have turned to AI for battling COVID-19, raising hopes and making headlines, the shortcomings of the studies have drawn the ire of numerous statistics experts.

The company, Nevada-based A-Medicare, is the brainchild of Italy-born actor, filmmaker and entrepreneur Enzo Zelocchi. 

Researchers have developed a new AI model that could be a game-changer in the treatment of blindness and vision loss.

A molecular diagnostics company is working with a genetic-health AI startup at breathing virtual life into a cognitive chatbot tasked with assisting individuals who may be at risk of hereditary cancer.

A deep learning model has achieved human-level proficiency in three of five exercises, accurately categorizing verbal expressions from more than 33,000 talk-therapy patients who underwent their sessions online.

The Mayo Clinic’s flagship campus in Minnesota is installing an AI-powered patient triage and prediction platform.

People have been anticipating the demise of radiologists for years, speculating that AI will soon be interpreting imaging results with the precision of a seasoned veteran.

Testicular cancer has a high survival rate, but the chemotherapy typically used during treatment can induce nephrotoxicity.